2021
DOI: 10.3390/ijms22126607
|View full text |Cite
|
Sign up to set email alerts
|

Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives

Abstract: Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been associated with excess mortality worldwide. The cardiovascular system is the second most common target of SARS-CoV-2, which leads to severe complications, including acute myocardial injury, myocarditis, arrhythmias, and venous thromboembolism, as well as other major thrombotic events because of direct endothelial injury and an excessive systemic inflammatory response. This review focuses on t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
46
0
4

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 63 publications
(50 citation statements)
references
References 104 publications
0
46
0
4
Order By: Relevance
“…The assessment of the arterial system indicated more frequent carotid plaques in post-SARS-CoV-2 participants compared with matched controls, while CIMT was comparable between groups. Whether this finding may be fully explained by the higher susceptibility of patients with the prevalent atherosclerotic disease for COVID-19 34,35 or to some extent also by common immunological pathways involved in SARS-CoV-2 infections and atherosclerosis 36 needs to be addressed in future longitudinal studies. Lower peak systolic flow velocities in the carotid arteries in patients after SARS-CoV-2 infection are in line with the trend towards a lower ejection fraction and presence of carotid plaques, as these parameters were reported to be associated recently.…”
Section: Discussionmentioning
confidence: 99%
“…The assessment of the arterial system indicated more frequent carotid plaques in post-SARS-CoV-2 participants compared with matched controls, while CIMT was comparable between groups. Whether this finding may be fully explained by the higher susceptibility of patients with the prevalent atherosclerotic disease for COVID-19 34,35 or to some extent also by common immunological pathways involved in SARS-CoV-2 infections and atherosclerosis 36 needs to be addressed in future longitudinal studies. Lower peak systolic flow velocities in the carotid arteries in patients after SARS-CoV-2 infection are in line with the trend towards a lower ejection fraction and presence of carotid plaques, as these parameters were reported to be associated recently.…”
Section: Discussionmentioning
confidence: 99%
“…These molecules mediate platelet agglutination, as well as monocyte-endothelial cell attachment. This event combined with the endothelial damage induced in the atrium of a patient affected by AF severely increases the risk of thrombus formation [ 56 , 57 , 58 ] ( Table 1 ).…”
Section: Inflammationmentioning
confidence: 99%
“…[1] , [2] , [3] , [4] , [5] , [6] , [7] , [9] , [10] , [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] , [31] , [32] , [33] , [34] , [35] , [36] , [37] , [38] , [39] , [40] , [41] , [42] .…”
Section: Uncited Referencesunclassified